Powered By
Levodopa Cyclops, an inhaled version of levodopa that PureIMS is developing as a treatment for off episodes with Parkinson’s disease, safely delivers levodopa to the body faster than an existing inhaled formulation of the therapy
That's according to results from a company-sponsored clinical trial (NCT06037590) comparing the pharmacological properties of Levodopa Cyclops against those of Inbrija, an approved inhaled powder formulation of levodopa developed by Acorda Therapeutics
After… read more
It would be helpful to have an unbiased opinion on this new medication
One consideration is would this work for people who have nausea and digestive symptoms from taking the pill version and another thought I had was would it be easier to administer if a person was having serious tremors and had to adminster their own medications and were experiencing a rebound of symptoms due to the levodopa wearing off making it difficult to take a pill
I'd be afraid people would take too much I know people abuse their dosages now
"Company sponsored trial". Speaking as a scientist, that sounds too much like marking your own work...
Good point Les. I wonder of the manufacturer has built in safeguards.
Join
Your Privacy Choices
